These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 9368297)

  • 1. Leukemia: lessons from the Japanese experience.
    Finch SC
    Stem Cells; 1997; 15 Suppl 2():135-9. PubMed ID: 9368297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer and non-cancer effects in Japanese atomic bomb survivors.
    Little MP
    J Radiol Prot; 2009 Jun; 29(2A):A43-59. PubMed ID: 19454804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukaemia following childhood radiation exposure in the Japanese atomic bomb survivors and in medically exposed groups.
    Little MP
    Radiat Prot Dosimetry; 2008; 132(2):156-65. PubMed ID: 18936088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987.
    Preston DL; Kusumi S; Tomonaga M; Izumi S; Ron E; Kuramoto A; Kamada N; Dohy H; Matsuo T; Matsui T [corrected to Matsuo T]
    Radiat Res; 1994 Feb; 137(2 Suppl):S68-97. PubMed ID: 8127953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-response relationship of neutrons and gamma rays to leukemia incidence among atomic bomb survivors in Hiroshima and Nagasaki by type of leukemia, 1950--1971.
    Ishimaru T; Otake M; Ischimaru M
    Radiat Res; 1979 Feb; 77(2):377-94. PubMed ID: 286375
    [No Abstract]   [Full Text] [Related]  

  • 6. [Health effects of atomic bomb radiation].
    Shigematsu I
    Rinsho Byori; 1994 Apr; 42(4):313-9. PubMed ID: 8176838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection, follow-up, and analysis in the Atomic Bomb Casualty Commission Study.
    Jablon S
    Natl Cancer Inst Monogr; 1985 May; 67():53-8. PubMed ID: 4047151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 1. Comparison of risk coefficients for site-specific cancer mortality based on the DS86 and T65DR shielded kerma and organ doses.
    Shimizu Y; Kato H; Schull WJ; Preston DL; Fujita S; Pierce DA
    Radiat Res; 1989 Jun; 118(3):502-24. PubMed ID: 2727272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation therapy among atomic bomb survivors, Hiroshima and Nagasaki.
    Kato K; Antoku S; Russell WJ; Fujita S; Pinkston JA; Hayabuchi N; Hoshi M; Kodama K
    Radiat Res; 1998 Jun; 149(6):614-24. PubMed ID: 9611100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality study of atomic-bomb survivors: implications for assessment of radiation accidents.
    Shimizu Y; Mabuchi K; Preston DL; Shigematsu I
    World Health Stat Q; 1996; 49(1):35-9. PubMed ID: 8896256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple myeloma among atomic bomb survivors in Hiroshima and Nagasaki, 1950-76: relationship to radiation dose absorbed by marrow.
    Ichimaru M; Ishimaru T; Mikami M; Matsunaga M
    J Natl Cancer Inst; 1982 Aug; 69(2):323-8. PubMed ID: 6955540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The observed relationship between the occurrence of acute radiation effects and leukemia mortality among A-bomb survivors.
    Neriishi K; Stram DO; Vaeth M; Mizuno S; Akiba S
    Radiat Res; 1991 Feb; 125(2):206-13. PubMed ID: 1996379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Male breast cancer incidence among atomic bomb survivors.
    Ron E; Ikeda T; Preston DL; Tokuoka S
    J Natl Cancer Inst; 2005 Apr; 97(8):603-5. PubMed ID: 15840883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of evidence for differences in the dose-response for cancer and non-cancer endpoints by acute injury status in the Japanese atomic-bomb survivors.
    Little MP
    Int J Radiat Biol; 2002 Nov; 78(11):1001-10. PubMed ID: 12456287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of the mortality of A-bomb survivors, report 7. Part III. incidence of cancer in 1959-1978, based on the tumor registry, Nagasaki.
    Wakabayashi T; Kato H; Ikeda T; Schull WJ
    Radiat Res; 1983 Jan; 93(1):112-46. PubMed ID: 6823504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychiatric sequelae in atomic bomb survivors in Hiroshima and Nagasaki two decades after the explosions.
    Yamada M; Izumi S
    Soc Psychiatry Psychiatr Epidemiol; 2002 Sep; 37(9):409-15. PubMed ID: 12242616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrons at Hiroshima: how their disappearance affected risk estimates.
    Ellett WH
    Radiat Res; 1991 Oct; 128(1 Suppl):S147-52. PubMed ID: 1924742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer risks and biomarker studies in the atomic bomb survivors.
    Preston D
    Stem Cells; 1995 May; 13 Suppl 1():40-8. PubMed ID: 7488967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignancies in atomic bomb survivors in Hiroshima and Nagasaki.
    Shimaoka K; Akiba S
    J Nucl Med Allied Sci; 1990; 34(4):254-9. PubMed ID: 2090789
    [No Abstract]   [Full Text] [Related]  

  • 20. An epidemiological study on leukemia in survivors exposed to the atomic bomb in childhood in Hiroshima. I.
    Shimizu K
    Hiroshima J Med Sci; 1968 Sep; 17(3):123-9. PubMed ID: 5717115
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.